PBTK modeling demonstrates contribution of dermal and inhalation exposure components to end-exhaled breath concentrations of naphthalene

Environmental Health Perspectives

Volumn 115, Issue 6, 2007, Pages 894-901

  Kim, David ^a   Andersen, Melvin E ^b   Chao, Yi Chun E ^a   Egeghy, Peter P ^a,c   Rappaport, Stephen M ^a   Nylander French, Leena A ^a  

^a IL   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Dermal; Exposure assessment; Inhalation; Jet fuel; Naphthalene; Physiologically based toxicokinetic model

Indexed keywords

NAPHTHALENE;

AIR FORCE; AIRCRAFT; ARTICLE; BIOLOGICAL MONITORING; BLOOD ANALYSIS; BODY FAT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EPIDERMIS; EXHALATION; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INHALATION; MALE; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN PERMEABILITY; STRATUM CORNEUM; TOXICOKINETICS; UNITED STATES; VOLUNTEER;

AIR POLLUTANTS, OCCUPATIONAL; BREATH TESTS; FEMALE; HUMANS; HYDROCARBONS; INHALATION EXPOSURE; MALE; MILITARY PERSONNEL; MODELS, BIOLOGICAL; NAPHTHALENES; OCCUPATIONAL EXPOSURE; PERMEABILITY; SKIN ABSORPTION; TIME FACTORS; UNITED STATES;

EID: 34250182073     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9778     Document Type: Article

References (33)

1. Abraham MH, Kamlet MJ, Taft RW, Doherty RM, Weathersby PK. 1985. Solubility properties in polymers and biological media. 2. The correlation and prediction of the solubilities of non-electrolytes in biological tissues and fluids. J Med Chem 28:865-870.
2. Agency for Toxic Substances and Disease Registry. 1995. Toxicological Profile for Naphthalene, 1-Methyl Napthalene, and 2-Methyl Naphthalene. Atlanta:Agency for Toxic Substances and Disease Registry.
3. Beliveau M, Tardif R, Krishnan K. 2003. Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats. Toxicol Appl Pharmacol 189:221-232.
4. Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407-484.
5. Chao YC, Gibson RL, Nylander-French LA. 2005. Dermal exposure to jet fuel (JP-8) in US Air Force personnel. Ann Occup Hyg 49:639-645.
6. Chao YC, Kupper LL, Serdar B, Egeghy PP, Rappaport SM, Nylander-French LA. 2006. Dermal exposure to jet fuel JP-8 significantly contributes to the production of urinary naphthols in fuel-cell maintenance workers. Environ Health Perspect 114:182-185.
7. Clewell HJ III, Andersen ME. 1996. Use of physiologically based pharmacokinetic modeling to investigate individual versus population risk. Toxicology 111:315-329.
8. Davies B, Morris T. 1993. Physiological parameters in laboratory animals and humans. Pharm Res 10(7):1093-1095.
9. Egeghy PP, Hauf-Cabalo L, Gibson R, Rappaport SM. 2003. Benzene and naphthalene in air and breath as indicators of exposure to jet fuel. Occup Environ Med 60:969-976.
10. Egeghy PP, Tornero-Velez R, Rappaport SM. 2000. Environmental and biological monitoring of benzene during self-service automobile refueling. Environ Health Perspect 108:1195-1202.
11. Evans MV, Andersen ME. 2000. Sensitivity analysis of a physiological model for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): assessing the impact of specific model parameters on sequestration in liver and fat in the rat. Toxicol Sci 54:71-80.
12. Fiserova-Bergerova V. 1983. Modeling of Inhalation Exposures to Vapors: Uptake, Distribution, and Elimination. Boca Raton, FL:CRC Press.
13. Fiserova-Bergerova V, Tichy M, Di Carlo FJ. 1984. Effects of biosolubility on pulmonary uptake and disposition of gases and vapors of lipophilic chemicals. Drug Metab Rev 15:1033-1070.
14. Gargas ML, Burgess RJ, Voisard DE, Cason GH, Andersen ME. 1989. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol Appl Pharmacol 98:87-99.
15. Guy RH, Potts RO. 1992. Structure-permeability relationships in percutaneous penetration. J Pharm Sci 81:603-604.
16. Hansch C, Hoekman D, Leo A, Zhang L, Li P. 1995. The expanding role of quantitative structure-activity relationships (QSAR) in toxicology. Toxicol Lett 79:45-53.
17. Haycock GB, Schwartz GJ, Wisotsky DH. 1978. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93:62-66.
18. Kim D, Andersen ME, Nylander-French LA. 2006a. Dermal absorption and penetration of jet fuel components in humans. Toxicol Lett 165:11-21.
19. Kim D, Andersen ME, Nylander-French LA. 2006b. A dermatotoxicokinetic model of human exposures to jet fuel. Toxicol Sci 93:22-33.
20. Levitt DG. 2004. Physiologically based pharmacokinetic modeling of arterial-antecubital vein concentration difference. BMC Clin Pharmacol 4:2.
21. McCarley KD, Bunge AL. 2001. Pharmacokinetic models of dermal absorption. J Pharm Sci 90:1699-719.
22. McDougal JN, Boeniger MF. 2002. Methods for assessing risks of dermal exposures in the workplace. Crit Rev Toxicol 32:291-327.
23. McDougal JN, Pollard DL, Weisman W, Garrett CM, Miller TE. 2000. Assessment of skin absorption and penetration of JP-8 jet fuel and its components. Toxicol Sci 55:247-255.
24. Mills TC. 2005. Predicting body fat using data on the BMI. J Stat Edu 13(2):1-3.
25. Perleberg UR, Keys DA, Fisher JW. 2004. Development of a physiologically based pharmacokinetic model for decane, a constituent of jet propellent-8. Inhal Toxicol 16:771-783.
26. Pleil JD, Smith LB, Zelnick SD. 2000. Personal exposure to JP-8 jet fuel vapors and exhaust at air force bases. Environ Health Perspect 108:183-192.
27. Qiao GL, Chang SK, Brooks JD, Riviere JE. 2000. Dermatoxicokinetic modeling of p-nitrophenol and its conjugation metabolite in swine following topical and intravenous administration. Toxicol Sci 54:284-294.
28. Quick DJ, Shuler ML. 1999. Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences. Biotechnol Prog 15:540-555.
29. Rustemeier K, Stabbert R, Haussmann HJ, Roemer E, Carmines EL. 2002. Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke. Food Chem Toxicol 40:93-104.
30. Serdar B, Egeghy PP, Waidyanatha S, Gibson R, Rappaport SM. 2003. Urinary biomarkers of exposure to jet fuel (JP-8). Environ Health Perspect 111:1760-764.
31. Willems BA, Melnick RL, Kohn MC, Portier CJ. 2001. A physiologically based pharmacokinetic model for inhalation and intravenous administration of naphthalene in rats and mice. Toxicol Appl Pharmacol 176:81-91.
32. Williams PL, Riviere JE. 1995. A biophysically based dermato-pharmacokinetic compartment model for quantifying percutaneous penetration and absorption of topically applied agents. I. Theory. J Pharm Sci 84:599-608.
33. Xcellon. 2004. acsIXtreme Optimum User's Guide, Version 1.4. Huntsville, AL:Xcellon.